Navigation Links
ElutraSep Inc. Announces the Launch of the Cryptonite™ HV Filter Module for Cryptosporidium and Giardia Testing
Date:5/15/2009

ElutraSep, Inc. today announced the commercial launch of the Cryptonite™ HV Filter Module for Cryptosporidium and Giardia testing. www.elutrasep.com/app-Cryptosporidium.asp.

Atlanta, GA (PRWEB) May 15, 2009 -- ElutraSep, Inc. today announced the commercial launch of the Cryptonite™ HV Filter Module for Cryptosporidium and Giardia testing. www.elutrasep.com/app-Cryptosporidium.asp

Cryptonite™ HV is a hollow fiber filtration module designed to capture and concentrate Cryptosporidium and Giardia from non-filtered source and finished water samples. Cryptonite™ HV recently underwent method development for method 1623 at an internationally recognized EPA approved laboratory located in Saint Albans, Vermont.

Testing of the new Cryptonite™ HV filter exceeded the recovery requirements set forth for EPA method 1623 and will now allow laboratories an additional choice for sample concentration. Cryptonite™ offers advantages including a recovery procedure with a total elution volume of less than 50 milliliters, no specialized elution equipment or post filtration required and a start to finish process that can be completed in about two minutes.

"We were always aware of the potential benefits that our technology could bring to the EPA 1623 method but lacked a high volume design that could accommodate turbid source waters. Last year, we began the process of designing a high volume module that would be cost competitive and offer substantial advantages over the competition," said Jason Holt, president and CEO of ElutraSep. " Laboratories will no longer have to conduct tedious elution protocols or have to deal with hundreds of milliliters of elution volumes. Module shakers, wash stations and multiple backwashing steps will be a thing of the past," said Jason. "We believe that the competitive costs of the modules, excellent recoveries and simplified workflows will quickly bring Cryptonite to the front of the pack".

Further information may be obtained by visiting the ElutraSep website www.elutrasep.com or by calling 770-781-5080

ElutraSep, Inc. provides concentration technologies and kits that aid in the detection of microorganisms from liquid samples. Primary product lines utilize inter-capillary capture of organisms via specially designed hollow fiber membranes.

ElutraSep products are typically applied to sample preparation stages of waterborne pathogen assays but are also applied to sterility testing programs in the food, beverage and pharmaceutical industries.

###

Read the full story at http://www.prweb.com/releases/2009/05/prweb2419224.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
3. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
4. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
5. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
6. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
11. CNS Response Announces Fiscal Third Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/23/2017)... ... ... NDA Partners Chairman Carl Peck, MD , announced today that John W. ... Center for Devices and Radiological Health and recognized leader in the medical device, pharmaceutical ... his FDA experience, Dr. Sheets served in senior technical leadership roles in a series ...
(Date:8/21/2017)... USA (PRWEB) , ... August 20, 2017 , ... ... the Journal of Biomedical Optics (JBO) starting 1 January 2018. The journal is ... of Biomedical Optics publishes papers on the use of modern optical technology for ...
(Date:8/21/2017)... ... August 21, 2017 , ... The team at ... educational webinar, in which attendees will learn about the assembly and topological architecture ... with an overview of the development and validation of new high-quality recombinant monoclonal ...
(Date:8/17/2017)... Westlake Village, CA (PRWEB) , ... August 17, ... ... biopsy technology for cancer research and personalized medicine, today announced the launch of ... in Kansas City, Missouri. The study’s goal is to evaluate the potential for ...
Breaking Biology Technology:
(Date:4/3/2017)... WASHINGTON , April 3, 2017 /PRNewswire-USNewswire/ ... single-cell precision engineering platform, detected a statistically ... cell product prior to treatment and objective ... highlight the potential to predict whether cancer ... prior to treatment, as well as to ...
(Date:3/30/2017)... , March 30, 2017 Trends, opportunities ... (physiological and behavioral), by technology (fingerprint, AFIS, iris recognition, ... recognition, and others), by end use industry (government and ... immigration, financial and banking, and others), and by region ... , Asia Pacific , and ...
(Date:3/27/2017)... , March 27, 2017  Catholic Health Services ... Management Systems Society (HIMSS) Analytics for achieving Stage ... Model sm . In addition, CHS previously earned ... hospitals using an electronic medical record (EMR). ... high level of EMR usage in an outpatient ...
Breaking Biology News(10 mins):